Navigation Links
Medtronic, Inc. and Medtronic Sofamor Danek, USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLC
Date:12/3/2008

ATLANTA, Dec. 3 /PRNewswire/ -- A patient who was surgically implanted with Medtronic's Infuse(R) Bone Graft product, for an off-label use promoted by Medtronic, suffocated due to severe throat and neck swelling, according to James A. Dunlap Jr. & Associates LLC and Page Perry, LLC who filed the lawsuit in California along with another national law firm.

The Complaint alleges, among other things, that Medtronic improperly promoted its Infuse(R) Bone Graft product for a cervical lumbar surgery procedure, when the product was not approved by the Food and Drug Administration for that use. Infuse(R) Bone Graft product may cause severe swelling in the neck and throat that restricts breathing and can lead to suffocation of the patient if used off-label for unapproved uses, particularly spinal surgery performed from the back.

"The Nisbet family is grieving the loss of Mrs. Nisbet, a beloved wife and mother," said James A. Dunlap, one of the attorneys representing the Nisbet family. "Because of Medtronic's wrongful conduct, many other patients like Shirley Nisbet may have improperly received Medtronic's Infuse(R) Bone Graft product for an off-label use," Mr. Dunlap added.

The FDA has received more than 200 reports of significant side effects resulting from off-label use of the medical device, particularly in the cervical spine, a number of which have led to serious and potentially life- threatening complications. According to the FDA, complications typically occur within two to 14 days after the implant surgery. Some individuals required insertion of feeding tubes, tracheotomies, anti-inflammatory drugs and additional surgery to drain the implant site. Data presented at a recent spine conference reflected a 59 percent complication rate in cervical spinal surgeries using Infuse(R). The study was conducted by a group of North Carolina surgeons between July 2005 and December 2007 and involved 76 patients.

Medtronic's Infuse(R) Bone Graft product has been the subject of a recent whistleblower lawsuit brought by former Medtronic employees who alleged that doctors received over $8 million in 2006 in "sham" consulting fees for using and promoting the Infuse(R) Bone Graft product. Medtronic's marketing and promotion of the device for off-label uses is being investigated by the United States Department of Justice. In addition, the United States Senate is conducting hearings into the matter. Medtronic previously settled for $40 million with the Justice Department on another whistleblower action alleging that, between 1998 and 2003, Medtronic's spinal products division paid kickbacks to doctors in a number of forms, including sham consulting agreements, sham royalty agreements and lavish trips to desirable locations.

The case is "Walter Nisbet et al. v. Medtronic, Inc. and Medtronic Safamor Danek USA, Inc., United States District Court, Central District of California, Case No. SACV08-1361-JVS (RNBx)."

For additional information contact James A. Dunlap Jr. & Associates LLC at 404-354-2363, http://www.jamesdunlaplaw.com, or Page Perry, LLC, at 770-673-0047, http://www.pageperry.com.


'/>"/>
SOURCE James A. Dunlap Jr. & Associates LLC; Page Perry, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. U.S. District Court in Delaware Reinstates Damage Awards to Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation
2. Shareholder Class Action Filed Against Medtronic, Inc. by The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Supreme Court Hears Case on Federal Pre-emption of Safety Standards for Medical Technologies (Riegel v. Medtronic, Inc.)
4. Amicus Brief Filed with U.S. Supreme Court in Riegel v. Medtronic, Inc.
5. Court Rejects Two Medtronic Patents
6. NuVasive Announces Patent Infringement Complaint Brought by Medtronic Sofamor Danek
7. Medtronic Celebration of Courage Set for September 13th
8. Medtronic Spine, Formerly Kyphon Inc., to Pay U.S. $75 Million to Resolve Allegations Of Defrauding Medicare
9. Medtronic Mediterranean Launches Worlds First Arabic-Language Integrated Insulin Therapy for Improved Diabetes Management
10. Wolf Popper Announces Filing of Securities Class Action Lawsuit Against Medtronic Inc. - MDT
11. Another Medtronic Sprint Fidelis Lead Lawsuit is Filed in Federal District Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... May 31, 2016 , ... ... Houston Healthconnect’s (Healthconnect) regional health information exchange, which enables physicians at SJMC’s two ... their patients from other participating organizations in the exchange. SJMC’s membership in the ...
(Date:5/31/2016)... ... May 31, 2016 , ... CallTrackingMetrics's ... advertising campaigns, to monitor the performance of sales and support staff, and to ... revenue. The software allows customers to record, transcribe, route, document, and report on ...
(Date:5/31/2016)... ... ... The Global Wellness Summit (GWS), an annual conference for international ... travel, spa and beauty in Europe. The organization asked its partner experts in Europe ... researchers - to forecast where wellness is headed in Europe. Predictions range from European ...
(Date:5/31/2016)... ... 2016 , ... Interest is on the rise for using the CRISPR-Cas9 system ... for RNAi hit validation. A key reason may be that high-throughput synthesis—combined with a ... RNA (crRNA) collections in arrayed formats. , Arrayed crRNA screens have ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Dr. Charles A. ... Dentistry of New Jersey in the class of 1986, where he graduated in the ... at his current location in Livingston since 1989. He has been a member in ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... 30, 2016 Eye expert s ... babies to seek an eye examination ...   Moorfields Eye Hospital Dubai, the first ... London , has identified premature babies as a special concern ... their particular vulnerability to retinopathy of prematurity (ROP). ROP is a ...
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharma company focused on the highly lucrative ... a substantial pipeline of potential first-in-class or best-in-class ... are in development with strategic partners. HCM,s profitable ... fast-growing domestic market. We expect progress of the ...
(Date:5/26/2016)... , May 26, 2016 According to ... Waste Management Market - U.S. Industry Analysis, Size, Share, Growth, ... market in the U.S. was valued at US$ 5.89 Bn ... of 3.4% from 2015 to 2023 to reach US$ 7.99 ... of current and emerging needle free drug delivery devices and ...
Breaking Medicine Technology: